Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.

There’s a reason why millions of people in the UK are on weight-loss injections – and it’s not because we’re all weak, writes ...

Danish drugmaker Novo Nordisk on Tuesday announced slashing prices of its weight-loss drug Wegovy by up to 37 per cent in a ...

Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s ...

Days after its rival Mounjaro emerged as the top-selling medicine in the country, Wegovy puts efforts to catch up ...